Akero Shows FGF21/GLP-1 Combo’s Potential In NASH And Type 2 Diabetes

 
• By Joseph Haas
Type 2 diabetes
Akero combo shows safety, efficacy in NASH patients with type 2 diabetes • Source: Shutterstock

More from Clinical Trials

More from R&D